610 related articles for article (PubMed ID: 25776138)
1. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
Diabetes Care; 2015 Apr; 38(4):716-22. PubMed ID: 25776138
[TBL] [Abstract][Full Text] [Related]
2. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group.
Heinemann L; Fleming GA; Petrie JR; Holl RW; Bergenstal RM; Peters AL
Diabetologia; 2015 May; 58(5):862-70. PubMed ID: 25784563
[TBL] [Abstract][Full Text] [Related]
3. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
Diabetes Care; 2020 Jan; 43(1):250-260. PubMed ID: 31806649
[TBL] [Abstract][Full Text] [Related]
4. Insulin Pump-Associated Adverse Events: A Qualitative Descriptive Study of Clinical Consequences and Potential Root Causes.
Estock JL; Codario RA; Keddem S; Zupa MF; Rodriguez KL; DiNardo MM
Diabetes Technol Ther; 2023 May; 25(5):343-355. PubMed ID: 36724310
[No Abstract] [Full Text] [Related]
5. Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type.
Ross P; Gray AR; Milburn J; Kumarasamy IM; Wu F; Farrand S; Armishaw J; Wiltshire E; Rayns J; Tomlinson P; Wheeler BJ
Acta Diabetol; 2016 Dec; 53(6):991-998. PubMed ID: 27585938
[TBL] [Abstract][Full Text] [Related]
6. Adolescent use of insulin and patient-controlled analgesia pump technology: a 10-year Food and Drug Administration retrospective study of adverse events.
Cope JU; Morrison AE; Samuels-Reid J
Pediatrics; 2008 May; 121(5):e1133-8. PubMed ID: 18450857
[TBL] [Abstract][Full Text] [Related]
7. Insulin Pump-Associated Adverse Events in a Brazilian Reference Center for the Treatment of Diabetes Mellitus: Proposal for a Taxonomy of Device Failures in Adults, Adolescents, and Children.
Neves ALD; Martins LEG; Gabbay MAL; Cavicchioli G; Tenorio FS; Cunha TS
J Diabetes Sci Technol; 2024 Jan; 18(1):74-81. PubMed ID: 35771027
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
Potti LG; Haines ST
J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
[TBL] [Abstract][Full Text] [Related]
9. Insulin Infusion Set Use: European Perspectives and Recommendations.
Deiss D; Adolfsson P; Alkemade-van Zomeren M; Bolli GB; Charpentier G; Cobelli C; Danne T; Girelli A; Mueller H; Verderese CA; Renard E
Diabetes Technol Ther; 2016 Sep; 18(9):517-24. PubMed ID: 27526329
[TBL] [Abstract][Full Text] [Related]
10. Clinical review: insulin pump-associated adverse events in adults and children.
Ross PL; Milburn J; Reith DM; Wiltshire E; Wheeler BJ
Acta Diabetol; 2015 Dec; 52(6):1017-24. PubMed ID: 26092321
[TBL] [Abstract][Full Text] [Related]
11. Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes.
Eugster EA; Francis G;
Pediatrics; 2006 Oct; 118(4):e1244-9. PubMed ID: 17015512
[TBL] [Abstract][Full Text] [Related]
12. Combined improvements in implantable pump technology and insulin stability allow safe and effective long term intraperitoneal insulin delivery in type 1 diabetic patients: the EVADIAC experience.
Gin H; Renard E; Melki V; Boivin S; Schaepelynck-Bélicar P; Guerci B; Selam JL; Brun JM; Riveline JP; Estour B; Catargi B;
Diabetes Metab; 2003 Dec; 29(6):602-7. PubMed ID: 14707889
[TBL] [Abstract][Full Text] [Related]
13. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group.
Fleming GA; Petrie JR; Bergenstal RM; Holl RW; Peters AL; Heinemann L
Diabetologia; 2020 Feb; 63(2):229-241. PubMed ID: 31802144
[TBL] [Abstract][Full Text] [Related]
14. Pediatric use of insulin pump technology: a retrospective study of adverse events in children ages 1-12 years.
Cope JU; Samuels-Reid JH; Morrison AE
J Diabetes Sci Technol; 2012 Sep; 6(5):1053-9. PubMed ID: 23063031
[TBL] [Abstract][Full Text] [Related]
15. Insulin pump-associated adverse events in children and adolescents--a prospective study.
Wheeler BJ; Heels K; Donaghue KC; Reith DM; Ambler GR
Diabetes Technol Ther; 2014 Sep; 16(9):558-62. PubMed ID: 24796368
[TBL] [Abstract][Full Text] [Related]
16. Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey.
Pickup JC; Yemane N; Brackenridge A; Pender S
Diabetes Technol Ther; 2014 Mar; 16(3):145-9. PubMed ID: 24180294
[TBL] [Abstract][Full Text] [Related]
17. Insulin Pump Malfunction During Hospitalization: Two Case Reports.
Faulds ER; Wyne KL; Buschur EO; McDaniel J; Dungan K
Diabetes Technol Ther; 2016 Jun; 18(6):399-403. PubMed ID: 27027151
[TBL] [Abstract][Full Text] [Related]
18. Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European Association for the Study of Diabetes and the American Diabetes Association.
Sherr JL; Heinemann L; Fleming GA; Bergenstal RM; Bruttomesso D; Hanaire H; Holl RW; Petrie JR; Peters AL; Evans M
Diabetologia; 2023 Jan; 66(1):3-22. PubMed ID: 36198829
[TBL] [Abstract][Full Text] [Related]
19. Insulin pump therapy in children with type 1 diabetes: the dark side of the moon.
Scaramuzza AE; Dell'Acqua M; Macedoni M; Zuccotti GV
J Diabetes Sci Technol; 2013 Jul; 7(4):1095-7. PubMed ID: 23911194
[No Abstract] [Full Text] [Related]
20. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
